Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 4
1988 2
1989 5
1990 11
1991 55
1992 98
1993 113
1994 200
1995 234
1996 205
1997 219
1998 183
1999 196
2000 228
2001 192
2002 242
2003 224
2004 222
2005 243
2006 232
2007 254
2008 287
2009 270
2010 287
2011 274
2012 309
2013 302
2014 345
2015 342
2016 295
2017 297
2018 287
2019 286
2020 348
2021 359
2022 336
2023 321
2024 250
2025 236
2026 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,976 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study.
Yuan S, Miao Y, Ruan X, Chen J, Li X, Larsson SC. Yuan S, et al. Front Immunol. 2023 Sep 14;14:1240754. doi: 10.3389/fimmu.2023.1240754. eCollection 2023. Front Immunol. 2023. PMID: 37781392 Free PMC article.
We applied the Mendelian randomization approach to explore whether higher interleukin-1 receptor antagonist (IL-1RA) levels reduce the risk of acute and chronic pancreatitis and pancreatic cancer. ...
We applied the Mendelian randomization approach to explore whether higher interleukin-1 receptor antagonist (IL- …
lnterleukin-1 Receptor Antagonist.
Lennard AC. Lennard AC. Crit Rev Immunol. 2017;37(2-6):531-559. doi: 10.1615/CritRevImmunol.v37.i2-6.160. Crit Rev Immunol. 2017. PMID: 29773033 Review.
The interleukin-1 receptor antagonist (IL-lra) is unusual in that it is the only known naturally occurring, cytokine receptor antagonist with no apparent agonist function. ...
The interleukin-1 receptor antagonist (IL-lra) is unusual in that it is the only known naturally occurring, cyto …
Injectable biomaterials for delivery of interleukin-1 receptor antagonist: Toward improving its therapeutic effect.
Clements AEB, Murphy WL. Clements AEB, et al. Acta Biomater. 2019 Jul 15;93:123-134. doi: 10.1016/j.actbio.2019.04.051. Epub 2019 Apr 25. Acta Biomater. 2019. PMID: 31029831 Review.
Interleukin-1 receptor antagonist (IL-1Ra) is a naturally occurring anti-inflammatory cytokine that inhibits IL-1 activity and has been proposed to treat a wide variety of systemic and local inflammatory pathologies for multiple decades. ...This litera …
Interleukin-1 receptor antagonist (IL-1Ra) is a naturally occurring anti-inflammatory cytokine that inhibits IL- …
Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus.
Akash MS, Shen Q, Rehman K, Chen S. Akash MS, et al. J Pharm Sci. 2012 May;101(5):1647-58. doi: 10.1002/jps.23057. Epub 2012 Jan 23. J Pharm Sci. 2012. PMID: 22271340 Review.
Currently, many anti-inflammatory therapeutic modalities are being investigated to abate the infuriating effects of inducers of T2DM and among them, interleukin-1 receptor antagonist (IL-1Ra) is the only one that has been approved by US Food and Drug A …
Currently, many anti-inflammatory therapeutic modalities are being investigated to abate the infuriating effects of inducers of T2DM and amo …
Association between interleukin 1 receptor antagonist gene 86-bp VNTR polymorphism and sepsis: a meta-analysis.
Fang F, Pan J, Li Y, Xu L, Su G, Li G, Wang J. Fang F, et al. Hum Immunol. 2015 Jan;76(1):1-5. doi: 10.1016/j.humimm.2014.12.013. Epub 2014 Dec 11. Hum Immunol. 2015. PMID: 25500257
OBJECTIVE: Many studies have focused on the relationship between interleukin 1 receptor antagonist (IL1RN) gene 86-bp VNTR polymorphism and sepsis, but the results remain inconsistent. ...
OBJECTIVE: Many studies have focused on the relationship between interleukin 1 receptor antagonist (IL1RN) gene …
Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.
Yamanaka G, Ishida Y, Kanou K, Suzuki S, Watanabe Y, Takamatsu T, Morichi S, Go S, Oana S, Yamazaki T, Kawashima H. Yamanaka G, et al. Int J Mol Sci. 2021 Jun 11;22(12):6282. doi: 10.3390/ijms22126282. Int J Mol Sci. 2021. PMID: 34208064 Free PMC article. Review.
Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic epilepsy syndrome, and the development of drug-resistant epilepsy (DRE) is inevitable. Recently, anakinra, an interleukin-1 receptor antagonist (IL-1RA), has been increasingly …
Febrile Infection-Related Epilepsy Syndrome (FIRES) is a unique catastrophic epilepsy syndrome, and the development of drug-resistant epilep …
7,976 results